150 related articles for article (PubMed ID: 26301650)
1. No evidence for increased prostate cancer risk among calcium channel blockers user.
Fan Y; Zhou Y; Gong D; Zou C
Int J Cardiol; 2015 Dec; 201():255-7. PubMed ID: 26301650
[No Abstract] [Full Text] [Related]
2. Use of calcium channel blockers in prostate cancer: Friends or foe?
Han QF; Ren XF; Wu L; Li T; Yao HC
Int J Cardiol; 2016 Jan; 203():740-1. PubMed ID: 26587732
[No Abstract] [Full Text] [Related]
3. Inverse association between prostate cancer and the use of calcium channel blockers.
Debes JD; Roberts RO; Jacobson DJ; Girman CJ; Lieber MM; Tindall DJ; Jacobsen SJ
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):255-9. PubMed ID: 14973089
[TBL] [Abstract][Full Text] [Related]
4. Re: Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis.
Severi G; English DR; Hopper JL; Giles GG
J Natl Cancer Inst; 2006 Jun; 98(11):794-5; author reply 795. PubMed ID: 16757704
[No Abstract] [Full Text] [Related]
5. Long term antihypertensive drug use and prostate cancer risk: A 9-year population-based cohort analysis.
Pai PY; Hsieh VC; Wang CB; Wu HC; Liang WM; Chang YJ; Wu TN
Int J Cardiol; 2015 Aug; 193():1-7. PubMed ID: 26002406
[TBL] [Abstract][Full Text] [Related]
6. Calcium channel blockers.
Hurwitz CU
CRNA; 1996 Feb; 7(1):29-32. PubMed ID: 8680353
[TBL] [Abstract][Full Text] [Related]
7. [Calcium blockers and their their present application].
Brzósko S; Hryszko T; Małyszko J; Myśliwiec M
Przegl Lek; 1999; 56(9):592-8. PubMed ID: 10695366
[TBL] [Abstract][Full Text] [Related]
8. Keeping cardiovascular disease in check with calcium channel blockers.
Griffith CJ
JAAPA; 1999 Jan; 12(1):53-8, 60, 62 passim. PubMed ID: 10728060
[No Abstract] [Full Text] [Related]
9. Calcium channel blockers in cardiovascular disease: current concepts and new clinical findings. Introduction.
Krakoff LR
Am J Hypertens; 1990 Dec; 3(12 Pt 2):289S-290S. PubMed ID: 2078314
[No Abstract] [Full Text] [Related]
10. [Role of calcium channel blockers in diseases of the circulatory system].
Adamska-Dyniewska H
Kardiol Pol; 1987; 30(1):55-61. PubMed ID: 3613400
[No Abstract] [Full Text] [Related]
11. Calcium channel blockers in the treatment of disease.
Elmslie KS
J Neurosci Res; 2004 Mar; 75(6):733-41. PubMed ID: 14994334
[TBL] [Abstract][Full Text] [Related]
12. Calcium channel blockers in cardiovascular disease: current concepts and new clinical findings. Symposium.
Am J Hypertens; 1990 Dec; 3(12 Pt 2):289s-371s. PubMed ID: 2078313
[No Abstract] [Full Text] [Related]
13. Calcium channel blockers and cancer: is there preclinical evidence for an association?
Ahr HJ; Bomhard E; Mager H; Schlüter G
Cardiology; 1997; 88 Suppl 3():68-72. PubMed ID: 9397298
[TBL] [Abstract][Full Text] [Related]
14. Calcium-channel blockers and the elderly.
Ryan C
Compr Ther; 1990 Jun; 16(6):51-4. PubMed ID: 2373003
[TBL] [Abstract][Full Text] [Related]
15. [Calcium antagonists: current and future applications based on new evidence. Classification of calcium channel blockers].
Takahara A
Clin Calcium; 2010 Jan; 20(1):24-30. PubMed ID: 20048430
[TBL] [Abstract][Full Text] [Related]
16. [Calcium channel blockers scare].
Zimlichman R
Harefuah; 1997 Feb; 132(3):223-5. PubMed ID: 9154732
[No Abstract] [Full Text] [Related]
17. Calcium channel blockers for cardiovascular disorders.
Karlsberg RP
Arch Intern Med; 1982 Mar; 142(3):452-5. PubMed ID: 6279045
[No Abstract] [Full Text] [Related]
18. [Prostate cancer epidemiology].
Beuzeboc P;
Soins; 2007 Mar; (713):32-3. PubMed ID: 17419566
[No Abstract] [Full Text] [Related]
19. [New studies using calcium channel blockers in diseases of the circulatory and respiratory systems].
Halawa B
Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1619-23. PubMed ID: 3295817
[No Abstract] [Full Text] [Related]
20. Prospective studies of dairy product and calcium intakes and prostate cancer risk: a meta-analysis.
Gao X; LaValley MP; Tucker KL
J Natl Cancer Inst; 2005 Dec; 97(23):1768-77. PubMed ID: 16333032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
